indications for glp 1 agonists The Role of Glucagon-Like Peptide-1 Receptor in the Treatment of Cardiovascular-Kidney-Metabolic Syndrome Frontiers | Mechanisms of action

They can provide a temporary boost in energy and metabolism, potentially assisting in kickstarting your weight loss journey, especially when combined with a healthy diet and regular exercise

The recently published randomised controlled Study of Tirzepatide Compared with Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes (SURPASS-CVOT) demonstrated that tirzepatide (up to 15 mg) was non-inferior to dulaglutide (1.5 mg) in reducing major adverse cardiovascular events (death from cardiovascular causes, myocardial infarction or stroke) in patients with T2DM and atherosclerotic CVD

& Rotwein, P

Practical Questions Q: How are these peptides administered

CPT codes 49650, 49651, and 44970 have updated GMCs of $6,902.69, $7,040.05, and $6,638.55 in the final rule data